Disrupted Glucose Metabolism in Irritable Bowel Syndrome: Targeting a Personalized Low-Glycemic Diet as a Potential Treatment Approach - Takeaway - MDSpire

Disrupted Glucose Metabolism in Irritable Bowel Syndrome: Targeting a Personalized Low-Glycemic Diet as a Potential Treatment Approach

Share

  • 1

    Patients with irritable bowel syndrome (IBS) exhibit impaired glucose metabolism, suggesting a need for glucose-targeted interventions.

  • 2

    A personalized low-glycemic diet (PLGD) demonstrated symptom improvement in IBS comparable to the established low-FODMAP diet (LFD).

  • 3

    The mechanistic basis for targeting glucose metabolism in IBS involves gut-brain axis dysregulation and immune activation.

  • 4

    PLGD maintains dietary diversity and optimizes individual metabolic responses, addressing limitations of traditional dietary strategies.

  • 5

    Integrating continuous glucose monitoring with digital platforms offers a scalable, personalized approach to IBS management.

Original Source(s)

Disrupted Glucose Metabolism in Irritable Bowel Syndrome: Targeting a Personalized Low-Glycemic Diet as a Potential Treatment Approach

  • by Franziska Schmelter, Torsten Schröder, Yves Laumonnier, OUTLIVE-CRC consortium, Stephan C Bischoff, Stefanie Derer, Benjamin Anderschou Holbech Jensen, Christian Sina

  • May 1, 2026

Related Content

Plastic Meets Biomass to Boost Biofuel Yields

Co-pyrolysis study reveals how agricultural waste and LDPE films work together to produce cleaner, energy-rich fuels

  • April 10, 2026

  • 2 min
Molecular Test Doubles Detection of Bile Duct Cancer

According to recent research, a new molecular test could detect bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of a patient’s diagnosis. 

New Histology Signal in Crohn’s

Distinct lymphoid structures identified in fibrostenosing Crohn’s specimens

  • March 26, 2026

  • 2 min